[Bone pseudoprogression due to renal neoplasia during treatment with immune checkpoint inhibitors]

Medicina (B Aires). 2022;82(6):997.
[Article in Spanish]
No abstract available

MeSH terms

  • Disease Progression
  • Humans
  • Immune Checkpoint Inhibitors*
  • Kidney Neoplasms* / diagnostic imaging
  • Kidney Neoplasms* / drug therapy
  • Nivolumab / adverse effects

Substances

  • Immune Checkpoint Inhibitors
  • Nivolumab